174 related articles for article (PubMed ID: 26294297)
1. Quantification of 11C-Laniquidar Kinetics in the Brain.
Froklage FE; Boellaard R; Bakker E; Hendrikse NH; Reijneveld JC; Schuit RC; Windhorst AD; Schober P; van Berckel BN; Lammertsma AA; Postnov A
J Nucl Med; 2015 Nov; 56(11):1730-5. PubMed ID: 26294297
[TBL] [Abstract][Full Text] [Related]
2. Radiation dose of the P-glycoprotein tracer 11C-laniquidar.
Postnov A; Froklage FE; van Lingen A; Reijneveld JC; Hendrikse NH; Windhorst AD; Schuit RC; Eriksson J; Lammertsma AA; Huisman MC
J Nucl Med; 2013 Dec; 54(12):2101-3. PubMed ID: 24092938
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of [11C]laniquidar as a tracer of P-glycoprotein: radiosynthesis and biodistribution in rats.
Luurtsema G; Schuit RC; Klok RP; Verbeek J; Leysen JE; Lammertsma AA; Windhorst AD
Nucl Med Biol; 2009 Aug; 36(6):643-9. PubMed ID: 19647170
[TBL] [Abstract][Full Text] [Related]
4. Quantification of Dynamic 11C-Phenytoin PET Studies.
Mansor S; Boellaard R; Froklage FE; Bakker ED; Yaqub M; Voskuyl RA; Schwarte LA; Verbeek J; Windhorst AD; Lammertsma A
J Nucl Med; 2015 Sep; 56(9):1372-7. PubMed ID: 26135114
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of tracer kinetic models for quantification of P-glycoprotein function using (R)-[11C]verapamil and PET.
Lubberink M; Luurtsema G; van Berckel BN; Boellaard R; Toornvliet R; Windhorst AD; Franssen EJ; Lammertsma AA
J Cereb Blood Flow Metab; 2007 Feb; 27(2):424-33. PubMed ID: 16757979
[TBL] [Abstract][Full Text] [Related]
6. Quantification of P-glycoprotein function at the human blood-brain barrier using [
Mossel P; Arif WM; De Souza GS; Varela LG; van der Weijden CWJ; Boersma HH; Willemsen ATM; Boellaard R; Elsinga PH; Borra RJH; Dierckx RAJO; Lammertsma AA; Bartels AL; Luurtsema G
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):3917-3927. PubMed ID: 37552369
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
[TBL] [Abstract][Full Text] [Related]
8. [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness.
Syvänen S; Russmann V; Verbeek J; Eriksson J; Labots M; Zellinger C; Seeger N; Schuit R; Rongen M; van Kooij R; Windhorst AD; Lammertsma AA; de Lange EC; Voskuyl RA; Koepp M; Potschka H
Nucl Med Biol; 2013 Aug; 40(6):764-75. PubMed ID: 23827307
[TBL] [Abstract][Full Text] [Related]
9. Kinetic Modeling and Test-Retest Reproducibility of
Naganawa M; Li S; Nabulsi N; Lin SF; Labaree D; Ropchan J; Gao H; Mei M; Henry S; Matuskey D; Carson RE; Huang Y
J Nucl Med; 2020 Nov; 61(11):1636-1642. PubMed ID: 32169917
[TBL] [Abstract][Full Text] [Related]
10. The influence of mass of [11C]-laniquidar and [11C]-N-desmethyl-loperamide on P-glycoprotein blockage at the blood-brain barrier.
Moerman L; Dumolyn C; Boon P; De Vos F
Nucl Med Biol; 2012 Jan; 39(1):121-5. PubMed ID: 21958857
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
12. Quantification of 18F-fluorocholine kinetics in patients with prostate cancer.
Verwer EE; Oprea-Lager DE; van den Eertwegh AJ; van Moorselaar RJ; Windhorst AD; Schwarte LA; Hendrikse NH; Schuit RC; Hoekstra OS; Lammertsma AA; Boellaard R
J Nucl Med; 2015 Mar; 56(3):365-71. PubMed ID: 25678491
[TBL] [Abstract][Full Text] [Related]
13. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Modeling of [
García-Varela L; Arif WM; Vállez García D; Kakiuchi T; Ohba H; Harada N; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Mol Pharm; 2020 Sep; 17(9):3477-3486. PubMed ID: 32787277
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic Modeling of (
García-Varela L; García DV; Kakiuchi T; Ohba H; Nishiyama S; Tago T; Elsinga PH; Tsukada H; Colabufo NA; Dierckx RAJO; van Waarde A; Toyohara J; Boellaard R; Luurtsema G
Mol Pharm; 2021 Jan; 18(1):416-428. PubMed ID: 33315404
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods.
Treyer V; Streffer J; Wyss MT; Bettio A; Ametamey SM; Fischer U; Schmidt M; Gasparini F; Hock C; Buck A
J Nucl Med; 2007 Jul; 48(7):1207-15. PubMed ID: 17574984
[TBL] [Abstract][Full Text] [Related]
17. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
[TBL] [Abstract][Full Text] [Related]
18. Kinetic modeling and long-term test-retest reproducibility of the mGluR5 PET tracer 18F-FPEB in human brain.
Leurquin-Sterk G; Postnov A; de Laat B; Casteels C; Celen S; Crunelle CL; Bormans G; Koole M; Van Laere K
Synapse; 2016 Apr; 70(4):153-62. PubMed ID: 26799447
[TBL] [Abstract][Full Text] [Related]
19. Retest imaging of [11C]NOP-1A binding to nociceptin/orphanin FQ peptide (NOP) receptors in the brain of healthy humans.
Lohith TG; Zoghbi SS; Morse CL; Araneta MD; Barth VN; Goebl NA; Tauscher JT; Pike VW; Innis RB; Fujita M
Neuroimage; 2014 Feb; 87():89-95. PubMed ID: 24225488
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of 3'-deoxy-3'-18F-fluorothymidine in patients with gliomas.
Muzi M; Spence AM; O'Sullivan F; Mankoff DA; Wells JM; Grierson JR; Link JM; Krohn KA
J Nucl Med; 2006 Oct; 47(10):1612-21. PubMed ID: 17015896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
